HealthPartners Institute | MedPath Search

Found 196 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "HealthPartners Institute"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Novel Post-Surgical Incision Management to Prevent Ostomy Complications

Not Applicable

Recruiting

Conditions: Enterocutaneous Fistula
Ostomy

Interventions: Device: Limpet
Device: Control

First Posted Date: 2024-07-29

Last Posted Date: 2024-11-22

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 92

Registration Number: NCT06524401

Locations: 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States

Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems

Phase 3

Recruiting

Conditions: Suicide Prevention

Interventions: Behavioral: 5S Trial

First Posted Date: 2024-07-17

Last Posted Date: 2024-07-17

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 60000

Registration Number: NCT06506344

Locations: 🇺🇸
HealthPartners Institute, Bloomington, Minnesota, United States
🇺🇸
Henry Ford Health, Detroit, Michigan, United States

Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis

Not Applicable

Recruiting

Conditions: Myasthenia Gravis

Interventions: Behavioral: Light Intensity Exercise
Behavioral: Moderate Intensity Exercise

First Posted Date: 2024-07-09

Last Posted Date: 2025-01-09

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 20

Registration Number: NCT06491238

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

HeartBeet Clinic Pilot Trial

Not Applicable

Completed

Conditions: Hyperlipidemia
Hypertension

First Posted Date: 2024-07-03

Last Posted Date: 2025-05-11

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 60

Registration Number: NCT06486532

Locations: 🇺🇸
Park Nicollet Cardiology, Saint Louis Park, Minnesota, United States

Measurement of Insulin Levels in the Cerebrospinal Fluid of Healthy Adults After a Single Intranasal Dose - Middle Age

Phase 1

Not yet recruiting

Conditions: Healthy

Interventions: Drug: Low Dose Regular insulin
Drug: High Dose Regular insulin
Other: 0.9% Saline

First Posted Date: 2024-05-30

Last Posted Date: 2025-05-13

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 18

Registration Number: NCT06434038

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.

Completed

Conditions: Parkinson Disease

Interventions: Device: Haptic module and insole device

First Posted Date: 2024-04-26

Last Posted Date: 2025-05-14

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 31

Registration Number: NCT06385392

Locations: 🇺🇸
Struthers Parkinson's Center, Golden Valley, Minnesota, United States
🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

Hepatitis C Lab Testing Comparison Study

Terminated

Conditions: Hepatitis C

Interventions: Diagnostic Test: Hepatitis C core antigen

First Posted Date: 2024-04-23

Last Posted Date: 2025-03-25

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 1

Registration Number: NCT06380166

Locations: 🇺🇸
HealthPartners, Bloomington, Minnesota, United States

Do Generic Volar Locking Plates Provide Similar Outcomes at a Reduced Cost?

Not Applicable

Completed

Conditions: Distal Radius Fractures

Interventions: Device: Generic Volar Locking Plate
Device: Conventional Volar Locking Plate

First Posted Date: 2024-04-02

Last Posted Date: 2024-08-28

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 101

Registration Number: NCT06343467

Locations: 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States

AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

Phase 1

Recruiting

Conditions: Thoracic Tumors
Non-small Cell Lung Cancer

Interventions: Drug: AMG 193
Drug: Carboplatin
Drug: Sotorasib
Drug: Paclitaxel
Drug: Pembrolizumab
Drug: Pemetrexed

First Posted Date: 2024-03-27

Last Posted Date: 2025-05-29

Lead Sponsor: Amgen

Target Recruit Count: 500

Registration Number: NCT06333951

Locations: 🇧🇷
Instituto do Cancer do Estado de Sao Paulo Octavio Frias de Oliveira Icesp, São Paulo, Brazil
🇬🇷
Alexandra Hospital, Athens, Greece
🇬🇷
Saint Luke Hospital, Thessaloniki, Greece

and more 62 locations

Feasibility of Lecanemab Registry and Clinical Outcome Measures

Conditions: Alzheimer Disease

Interventions: Drug: Lecanemab

First Posted Date: 2024-02-29

Last Posted Date: 2025-01-24

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 20

Registration Number: NCT06285448

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States